Cargando…

Comparative analysis of the immunogenicity of SARS-CoV nucleocapsid DNA vaccine administrated with different routes in mouse model

The development of strategies to augment the immunogenicity of DNA vaccines is critical for improving their clinical utility. One such strategy involves using the different immune routes with DNA vaccines. In the present study, the immunogenicity of SARS-CoV nucleocapsid DNA vaccine, induced by usin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Hui, Huang, Xianqing, Tao, Ling, Huang, Yi, Cui, Bao-an, Wang, Hanzhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2009
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115532/ https://www.ncbi.nlm.nih.gov/pubmed/19186202 http://dx.doi.org/10.1016/j.vaccine.2009.01.021

Ejemplares similares

Enhancing immune responses against SARS-CoV nucleocapsid DNA vaccine by co-inoculating interleukin-2 expressing vector in mice
por: Hu, Hui, et al.
Publicado: (2009)

Immunogenicity and In Vivo Protective Effects of Recombinant Nucleocapsid-Based SARS-CoV-2 Vaccine Convacell(®)
por: Rabdano, Sevastyan O., et al.
Publicado: (2023)

Boosted expression of the SARS-CoV nucleocapsid protein in tobacco and its immunogenicity in mice
por: Zheng, Nuoyan, et al.
Publicado: (2009)

Assessment of Immunogenic and Antigenic Properties of Recombinant Nucleocapsid Proteins of Five SARS-CoV-2 Variants in a Mouse Model
por: Rak, Alexandra, et al.
Publicado: (2023)

DNA Folding by the SARS-CoV-2 Nucleocapsid Protein
por: Choi, Youna N., et al.
Publicado: (2021)

Measuring DNA folding by the SARS-CoV-2 nucleocapsid protein
por: Kim, Jake J., et al.
Publicado: (2023)

Nucleocapsid protein binding DNA aptamers for detection of SARS-COV-2
por: Neff, Charles P., et al.
Publicado: (2023)

The investigation of mRNA vaccines formulated in liposomes administrated in multiple routes against SARS-CoV-2
por: Huang, Hai, et al.
Publicado: (2021)

Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies
por: Dobaño, Carlota, et al.
Publicado: (2021)

Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates
por: Liu, Shih-Jen, et al.
Publicado: (2006)

The Immunogenicity of Capsid-Like Particle Vaccines in Combination with Different Adjuvants Using Different Routes of Administration
por: Janitzek, Christoph M., et al.
Publicado: (2021)

The Nucleocapsid Protein of SARS–CoV-2: a Target for Vaccine Development
por: Dutta, Noton K., et al.
Publicado: (2020)

Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine
por: Zhao, Ping, et al.
Publicado: (2005)

Modular characterization of SARS-CoV-2 nucleocapsid protein domain functions in nucleocapsid-like assembly
por: Wang, Yan, et al.
Publicado: (2023)

SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens
por: Gupta, Vandana, et al.
Publicado: (2006)

Enhancement of the immunogenicity of an infectious bronchitis virus DNA vaccine by a bicistronic plasmid encoding nucleocapsid protein and interleukin-2
por: Tang, Mengjun, et al.
Publicado: (2008)

Safety and Immunogenicity of an HIV Adenoviral Vector Boost after DNA Plasmid Vaccine Prime by Route of Administration: A Randomized Clinical Trial
por: Koblin, Beryl A., et al.
Publicado: (2011)

Detection of SARS-CoV-2 Nucleocapsid, Spike, and Neutralizing Antibodies in Vaccinated Japanese
por: Midorikawa, Rie, et al.
Publicado: (2022)

The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development
por: Yu, Haiyun, et al.
Publicado: (2023)

The expression of membrane protein augments the specific responses induced by SARS-CoV nucleocapsid DNA immunization
por: Shi, Shu-Qun, et al.
Publicado: (2006)

Small interfering RNA inhibits SARS‐CoV nucleocapsid gene expression in cultured cells and mouse muscles
por: Zhao, Ping, et al.
Publicado: (2005)

The Epitope Study on the SARS-CoV Nucleocapsid Protein
por: Li, Shuting, et al.
Publicado: (2003)

Immunogenicity of Multiple Doses of pDNA Vaccines against SARS-CoV-2
por: Almansour, Iman, et al.
Publicado: (2021)

Immunogenicity of candidate SARS-CoV-2 DNA vaccines based on the spike protein
por: Lim, Heeji, et al.
Publicado: (2022)

Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses
por: Bai, Bingke, et al.
Publicado: (2008)

A DNA Aptamer Based Method for Detection of SARS-CoV-2 Nucleocapsid Protein
por: Chen, Zhiqiang, et al.
Publicado: (2020)

Electrostatic features for nucleocapsid proteins of SARS-CoV and SARS-CoV-2
por: Guo, Wenhan, et al.
Publicado: (2021)

Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2
por: Dangi, Tanushree, et al.
Publicado: (2021)

Search for potential target site of nucleocapsid gene for the design of an epitope-based SARS DNA vaccine
por: Dutta, Noton Kumar, et al.
Publicado: (2008)

579. Design and Immunogenicity of a Pan-SARS-CoV-2 Synthetic DNA Vaccine
por: Schultheis, Katherine, et al.
Publicado: (2021)

The SARS coronavirus nucleocapsid protein – Forms and functions
por: Chang, Chung-ke, et al.
Publicado: (2014)

Immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccines in healthy adults
por: Wu, Yufei, et al.
Publicado: (2023)

Biochemical characterization of SARS-CoV-2 nucleocapsid protein
por: Zeng, Weihong, et al.
Publicado: (2020)

Antibody detection of SARS-CoV spike and nucleocapsid protein
por: Chang, Mau-Sun, et al.
Publicado: (2004)

Identification and functional analysis of the SARS-COV-2 nucleocapsid protein
por: Gao, Tianyi, et al.
Publicado: (2021)

SARS-CoV-2 nucleocapsid and Nsp3 binding: an in silico study
por: Khan, Muhammad Tahir, et al.
Publicado: (2020)

Immunogenicity of SARS-CoV-2 vaccines in patients with cancer
por: Kakkassery, Helen, et al.
Publicado: (2022)

Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets
por: Oliveira, Sergio C., et al.
Publicado: (2020)

Targeting intra-viral conserved nucleocapsid (N) proteins as novel vaccines against SARS-CoVs
por: Thura, Min, et al.
Publicado: (2021)

Nucleocapsid protein of SARS‐CoV‐2 is a potential target for developing new generation of vaccine
por: Feng, Weixu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qekchgo5q1v31aajg25bm4lsqa